USE OF NEW CYTOSTATICS IN SCHEDULES OF THERAPY OF PATIENTS WITH HODGKIN’S LYMPHOMA AND NON- HODGKIN’S MALIGNANT LYMPHOMAS
The objective of a study is a formation of new schedules of polychemotherapy using preparations never used before for thetreatment of lymphoproliferative diseases. 374 patientswith refractorymalignant lymphomasreceived treatment in the Department of Systemic Tumor Diseases of Institute of Oncology AMS of Ukraine. It is proved that useof schedules cis-BEACOPPGEM-BEACOPPincrea- ses 3-year survival up to 77.0 ± 7.8% and total survival of the patients up to 84.1 ± 5.1%.
No comments » Add comment